Gilead Sciences Quote - GIS

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

89.74

Bid

89.64

Ask

89.83

Volume

4,295

88.37 Day's Range 89.63

57.18 52 Week Range 92.77

Market Cap

111.84B

Previous Close

88.76

Open

88.55

Last Trade

100

89.63

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

5,783

Shares Outstanding

1,246,265,857

Dividend Yield

3.58%

PE Ratio

20.77

Earnings Per Share (EPS)

4.55

Revenue

27.12B

Net Profit

5.67B

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.gilead.com

Headquarters

Wilmington, Delaware, USA

Founded

Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 88.76 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57.18 € to 92.77 €.

Gilead Sciences currently has 1,246,265,857 shares outstanding. The market capitalization of Gilead Sciences is 110.62 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 20.77.

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...

World Health Organisation 'strongly recommends' Pfizer's covid pill

The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.24	2.56	87.5	89.63	86.41	3701	88.07763132	DE
4	3.59	4.16715031921	86.15	90.44	85.25	5546	88.36631012	DE
12	15.43	20.7643654959	74.31	92.77	74.16	5783	85.10772999	DE
26	23.24	34.9473684211	66.5	92.77	60.77	5048	77.30292004	DE
52	17.58	24.3625277162	72.16	92.77	57.18	5242	72.08470402	DE
156	26.24	41.3228346457	63.5	92.77	52.06	4408	70.83566423	DE
260	29.82	49.7663551402	59.92	92.77	46.165	10757	65.42691371	DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?

The current share price of Gilead Sciences is 89.74 €

How many Gilead Sciences shares are in issue?

Gilead Sciences has 1,246,265,857 shares in issue

What is the market cap of Gilead Sciences?

The market capitalisation of Gilead Sciences is EUR 110.62B

What is the 1 year trading range for Gilead Sciences share price?

Gilead Sciences has traded in the range of 57.18 € to 92.77 € during the past year

What is the PE ratio of Gilead Sciences?

The price to earnings ratio of Gilead Sciences is 20.77

What is the cash to sales ratio of Gilead Sciences?

The cash to sales ratio of Gilead Sciences is 4.34

What is the reporting currency for Gilead Sciences?

Gilead Sciences reports financial results in USD

What is the latest annual turnover for Gilead Sciences?

The latest annual turnover of Gilead Sciences is USD 27.12B

What is the latest annual profit for Gilead Sciences?

The latest annual profit of Gilead Sciences is USD 5.67B

What is the registered address of Gilead Sciences?

The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Gilead Sciences website address?

The website address for Gilead Sciences is www.gilead.com

Which industry sector does Gilead Sciences operate in?

Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
0RARAPT Therapeutics Inc	1.61 € (101.25%)	83.81k
KASHIntellabridge Technology Corp	0.047 € (88.00%)	1.24M
4APApollo Minerals Ltd	0.01 € (66.67%)	30
AWY0Percheron Therapeutics Ltd	0.007 € (55.56%)	660k
1W81WISeKey International Holding Ltd	9.70 € (44.78%)	4.81k
WWTWater Ways Technologies Inc	0.0045 € (-95.91%)	2.53k
L7C2Windfall Geotek Inc	0.0025 € (-70.59%)	40k
QP9Atco Mining Inc	0.003 € (-55.88%)	1.5k
0PV2Moovly Media Inc	0.002 € (-55.56%)	500
8QPFidus Investment Corp	9.5899 € (-51.32%)	220
013CJDcom Inc	17.426 € (0.00%)	0
013AJD.com Inc	34.90 € (0.00%)	0
0110Thesis Gold Inc	0.391 € (0.00%)	0
00WAspermont Ltd	0.004 € (0.00%)	0
000Greenvolt Energias Renovaveis SA	0.00 € (0.00%)	0